182 related articles for article (PubMed ID: 35968185)
1. Role of S100 A7 as a diagnostic biomarker in oral potentially malignant disorders and oral cancer.
Sood A; Mishra D; Kharbanda OP; Chauhan SS; Gupta SD; Deo SSV; Yadav R; Ralhan R; Kumawat R; Kaur H
J Oral Maxillofac Pathol; 2022; 26(2):166-172. PubMed ID: 35968185
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Babiuch K; Kuśnierz-Cabala B; Kęsek B; Okoń K; Darczuk D; Chomyszyn-Gajewska M
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245251
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.
Rani NAJ; Vardhan BGH; Srinivasan S; Gopal SK
Ann Maxillofac Surg; 2023; 13(1):70-75. PubMed ID: 37711518
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Mast Cells in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Shrestha A; Keshwar S; Raut T
Int J Dent; 2021; 2021():5609563. PubMed ID: 34490052
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.
Lorini L; Tomasoni M; Gurizzan C; Magri C; Facchetti M; Battocchio S; Romani C; Ravanelli M; Oberti A; Bozzola A; Bardellini E; Paderno A; Mattavelli D; Lombardi D; Grammatica A; Deganello A; Facchetti F; Calza S; Majorana A; Piazza C; Bossi P
Front Oncol; 2022; 12():886404. PubMed ID: 35530364
[TBL] [Abstract][Full Text] [Related]
6. Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Raghunandan BN; Sanjai K; Kumaraswamy J; Papaiah L; Pandey B; Jyothi BM
J Oral Maxillofac Pathol; 2016; 20(1):96-101. PubMed ID: 27194869
[TBL] [Abstract][Full Text] [Related]
7. Serum and Saliva LDH Levels in Patients with Habit, Oral Potentially Malignant Disorders (OPMDs), and Oral Squamous Cell Carcinoma (OSCC): A Spectrophotometry Study.
Shah FY; Shetty DC; Kaur G; Gupta S; Pathak A; Aggarwal V
J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 2):S881-S884. PubMed ID: 37694076
[TBL] [Abstract][Full Text] [Related]
8. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant-Oxidant Index as a Biomarker in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Biochemical Study.
Juneja S; Rathore AS; Sharma K; Shetty D; Jain A
J Clin Diagn Res; 2017 Mar; 11(3):ZC05-ZC08. PubMed ID: 28511498
[TBL] [Abstract][Full Text] [Related]
10. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Study of the Cancer Stem Cells' Biomarker CD147 in Leukoplakia: Dysplasia and Squamous Cell Carcinoma of Oral Epithelial Origin.
Zisis V; Andreadis D; Anastasiadou P; Vahtsevanos K; Akrivou M; Vizirianakis IS; Poulopoulos A
Cureus; 2023 May; 15(5):e38807. PubMed ID: 37303447
[TBL] [Abstract][Full Text] [Related]
12. S100 proteins in oral squamous cell carcinoma.
Raffat MA; Hadi NI; Hosein M; Mirza S; Ikram S; Akram Z
Clin Chim Acta; 2018 May; 480():143-149. PubMed ID: 29453969
[TBL] [Abstract][Full Text] [Related]
13. A Preliminary Study of the Role of Endothelial-Mesenchymal Transitory Factor SOX 2 and CD147 in the Microvascularization of Oral Squamous Cell Carcinoma.
Zisis V; Anastasiadou PA; Poulopoulos A; Vahtsevanos K; Paraskevopoulos K; Andreadis D
Cureus; 2024 Jan; 16(1):e52265. PubMed ID: 38352102
[TBL] [Abstract][Full Text] [Related]
14. Morphometric analysis of basal cells of oral epithelium in predicting malignant transformation of oral potentially malignant disorders in patients with tobacco chewing habit.
Santoshi CK; Kumar JV; Bhagirath PV; Vinay BH; Prakash YJ
J Oral Maxillofac Pathol; 2020; 24(3):579. PubMed ID: 33967506
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.
Yap T; Celentano A; Seers C; McCullough MJ; Farah CS
J Oral Pathol Med; 2020 Jan; 49(1):1-8. PubMed ID: 31309636
[TBL] [Abstract][Full Text] [Related]
16. The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.
Lin SC; Liu CJ; Ji SH; Hung WW; Liu YC; Chang SR; Tu HF; Chang KW
Clin Oral Investig; 2022 Feb; 26(2):1343-1351. PubMed ID: 34342761
[TBL] [Abstract][Full Text] [Related]
17. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer.
Chang YT; Chu LJ; Liu YC; Chen CJ; Wu SF; Chen CH; Chang IY; Wang JS; Wu TY; Dash S; Chiang WF; Chiu SF; Gou SB; Chien CY; Chang KP; Yu JS
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823758
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders.
de Vicente JC; Rodríguez-Santamarta T; Rodrigo JP; Allonca E; Vallina A; Singhania A; Donate-Pérez Del Molino P; García-Pedrero JM
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31484317
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Srinivasan V; Shyam N; Kumar GK; Narayen V; Konda P; Swetha Rani K
Cureus; 2023 May; 15(5):e38467. PubMed ID: 37273383
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.
Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
